Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2026-01-25 @ 11:06 AM
Study NCT ID:
NCT06770257
Status:
WITHDRAWN
Last Update Posted:
2025-06-03
First Post:
2025-01-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Daunorubicin, Cytarabine Liposomes Plus Venetoclax vs Azacitidine Plus Venetoclax in AML Patients Unfit for Intensive Chemotherapy
Sponsor:
Institute of Hematology & Blood Diseases Hospital, China
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Leukemia, Myeloid, Acute | View |
Keywords: